Teva Pharmaceutical Industries
TEVA
$16.93
Share price
0.18%
Change (1 day)
135.14%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Net assets
Net assets on the balance sheet as of March 2024 : $7.54 B
According to Teva Pharmaceutical Industries's latest financial reports the company has $7.54 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Teva Pharmaceutical Industries - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $8.12 B | -5.49% |
| 2022-12-31 | $8.59 B | -23.53% |
| 2021-12-31 | $11.24 B | 1.65% |
| 2020-12-31 | $11.06 B | -26.57% |
| 2019-12-31 | $15.06 B | -4.63% |
| 2018-12-31 | $15.79 B | -15.74% |
| 2017-12-31 | $18.74 B | -46.43% |
| 2016-12-31 | $34.99 B | 16.93% |
| 2015-12-31 | $29.92 B | 28.14% |
| 2014-12-31 | $23.35 B | 3.18% |
| 2013-12-31 | $22.63 B | -1.01% |
| 2012-12-31 | $22.86 B | 2.35% |
| 2011-12-31 | $22.34 B | 1.55% |
| 2010-12-31 | $22.00 B | 14.24% |
| 2009-12-31 | $19.25 B | 17.72% |
| 2008-12-31 | $16.36 B | 18.9% |
| 2007-12-31 | $13.76 B | 23.11% |
| 2006-12-31 | $11.17 B | 84.74% |
| 2005-12-31 | $6.05 B | 12.04% |
| 2004-12-31 | $5.40 B | 63.83% |
| 2003-12-31 | $3.29 B | 79.69% |
| 2002-12-31 | $1.83 B | 32.65% |
| 2001-12-31 | $1.38 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $39.75 B | 427.06% | 🇨🇭 Switzerland |
 Pfizer PFE | $92.55 B | 1,127.07% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 989.80% | 🇫🇷 France |
 Merck MRK | $40.42 B | 435.91% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | 397.16% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $16.71 B | 121.63% | 🇬🇧 UK |
 Dr. Reddy's RDY | $3.21 B | -57.34% | 🇮🇳 India |